Business · 16/01/2014Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of Argent Laboratories' New Animal Drug Applications
Summary
The US Food and Drug Administration (FDA) is updating its animal drug regulations to reflect the withdrawal of approval for two new animal drug applications (NADAs) submitted by Argent Laboratories, following the company's request due to the products no longer being manufactured or marketed.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →